Lilly, GE to study cancer therapies
Eli Lilly and Co. launched a three-year collaboration today with GE Global Research, the central research and development unit of New York-based General Electric Co. The companies will develop diagnostic tools to predict patients’ response to targeted cancer therapies. Lilly is in the testing phase for compounds that would aim chemotherapy at specific cancer cells; […]